Depleting the Gut Microbiota Protects From Obesity
18 Nov 2015 --- In the past few years, research on gut microbiota has started to unravel its tremendous role in our body, and how it symbiotically affects the functioning of our organs. In particular, microbiota has also an impact on the way calories are absorbed and how fat cells develop.
By studying mice without microbiota, scientists from the University of Geneva (UNIGE) Faculty of Medicine, Switzerland, were able to demonstrate how the absence of microbiota has a remarkable effect against obesity. Indeed, it triggers a surprising metabolic mechanism: white fat cells - which in excess cause obesity and insulin resistance - are transformed into cells similar to brown fat (they are called "beige fat"), that protects the body against excess weight and its damaging consequences. This discovery, published in Nature Medicine, could open the door to completely new anti-obesity treatments.
Mammals have two types of fat: brown fat, whose primary function is to burn calories to produce heat; and white fat, which is used as energy storage. In healthy humans, white adipose tissue constitutes about 25% of the body mass. However, when in excess, white fat contributes to insulin resistance and diabetes. Conversely, brown fat improves insulin sensitivity and is reversely correlated to obesity.
In response to cold or exercise, cells similar to brown fat - the beige fat - can appear within the white fat, a phenomenon known as "browning". Although the origin of these beige cells seems alike to that of the white fat, their function differs: the more beige fat that appears within the white adipose tissue, the more calories are burned. This suggests that stimulating beige fat growth could be a way to reduce obesity and limit insulin resistance.
Only recently, scientists have started to grasp the extent of the relationships between the gut microbiota and its human host. An increasing number of studies are now highlighting its impact on the regulation of multiple metabolic pathways, thus interconnecting the gastrointestinal tract, skin, liver, brain and many other organs.
Today, researchers from UNIGE Faculty of Medicine demonstrate that it also has a direct impact on obesity: the microbiota of obese people has a specific composition, different from the microbiota of lean people. Indeed, germ-free mice (born and kept in sterile conditions, i.e. without microbiota), which receive gut microbiota transplant from obese people, tend to develop obesity and insulin resistance.
"Having observed that microbiota can affect the obesity onset, we suspected that microbiota depletion can change the insulin sensitivity by modifying the amount and balance of these various types of fat", explains Mirko Trajkovski, lead author of the study and Professor at the Faculty of Medicine Department of Cell Physiology and Metabolism. To confirm their hypothesis, the researchers fed three groups of mice with a high-calorie diet: germ-free mice, standard mice and mice previously treated with high doses of antibiotics that have the effect of totally depleting their microbiota. While normal mice exposed to a high-calorie diet did develop obesity and insulin resistance, the two other groups remained lean, had an improved sensitivity to insulin and tolerated glucose better. Importantly, their amount of white fat decreased, and this was accompanied with increased levels of brown fat markers.
The scientists observed that depleting microbiota - either through antibiotics or in germ-free mice - stimulated the development of functional beige fat within the white fat, in the same way as when exposed to cold or exercise. But how does this work? It all has to do with a specific cell type, called macrophages. Macrophages are an essential component of the immune system and fulfil various metabolic functions, including tissue remodeling. They express different functional programmes in response to micro-environmental signals, a process called "polarization".
Polarized macrophages can be broadly classified in two main groups: M1 and M2, the latter being able to act on the adipose and increase the production of beige fat. When the microbiota is depleted, the number of specific cells, called eosinophils, increases in white fat, which secretes small signaling proteins ("type 2 cytokines") that act on macrophages polarization. Thanks to these proteins, M1 macrophages turn into M2 macrophages, which activate the browning of white fat and reduce obesity.
"In mice, the effect of the antibiotics lasts for a couple of weeks after the treatment", stress Nicolas Suarez-Zamorano and Salvatore Fabbiano, the first co-authors of this study. "Although treating obesity with high doses of antibiotics is unrealistic - mainly due to the risk of antibiotic resistance - we want to explore alternative ways of suppressing or modifying the microbiota, and to identify the exact bacterial genes responsible for this phenomenon. We would then target only those, without having to deplete the entire microbiota", explains Mirko Trajkovski.
To search for effective clinical treatments of obesity, the scientists will use particular antibiotics, as well as bacterial phages, a kind of virus that kills only specific bacterial strains. The possibility of microbiota transplant from a lean to an obese person whose microbiota would have been previously depleted will also be studied.
This study should not serve as an incentive to deplete gut bacteria through antibiotics. Outside of lab conditions, this leads to dysbiosis – the overgrowth of pathogenic bacteria, which has been shown to increase the incidence of obesity and insulin resistance. Creating an environment where the beneficial bacteria outweighs the pathogenic is the best way to maintain balance and a healthy weight.
Neither does it take into account the incredibly complex interplay between all types of bacteria in the gut – both pathogenic and beneficial, both of which suspected to be necessary for good health, in the right ratios. Simply depleting specific types of bacteria purely for weight loss may lead to unforeseen side effects in other areas of health. More research is needed at these very early stages of microbiota research.
